Showing results (111-120 of 179) with videos related to
Sort By:
Pageof 18
Breast Cancer Research and Treatment|March 7, 2012
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effortSerena Masciari, Deborah A Dillon, Michelle Rath, et al.The Journal of Molecular Diagnostics : JMD|July 25, 2015
A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 PatientsStephen E Lincoln, Yuya Kobayashi, Michael J Anderson, et al.Genetic Epidemiology|March 7, 2026
Evaluating a Mendelian Risk Prediction Model That Aggregates Across Genes and CancersJane W Liang, Gregory E Idos, Christine Hong, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer riskAllison W Kurian, Meredith A Mills, Margo Jaffee, et al.The Journal of Molecular Diagnostics : JMD|February 19, 2020
Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test PanelAva Kwong, Vivian Y Shin, Jiawei Chen, et al.Cancer Research|January 14, 2010
Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomasJoshua D Schiffman, J Graeme Hodgson, Scott R VandenBerg, et al.Research Square|February 26, 2024
Repurposing mebendazole against triple-negative breast cancer leptomeningeal diseaseAdrian Rodrigues, Sophia B Chernikova, Yuelong Wang, et al.DNA Repair|July 18, 2019
Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissueLisa A McPherson, Clara I Troccoli, Debin Ji, et al.Familial Cancer|May 29, 2012
Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutationsMonique A de Bruin, Ava Kwong, Benjamin A Goldstein, et al.Scientific Reports|March 21, 2020
Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancerLi C Xia, Paul Van Hummelen, Matthew Kubit, et al.Pageof 18